hydroxyacyl-Coenzyme A dehydrogenase, type II isoform 1; 3-hydroxyacyl-CoA dehydrogenase type II; Type II HADH; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; Endoplasmic reticulum-associated amyloid beta-peptide binding protein; Short-chain type dehydrogenase/reductase XH98G2 ; ERAB, HSD17B10, SCHAD; HADH2 protein
Synthetic peptide from the C-terminal region of ABAD conjugated to KLH.
Ordering Information
Pierce ABAD Polyclonal Antibody
Product Number
Pkg. Size
Price
Purchase
PA5-13330
100 µg
$299.00
Storage:
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Form:
100 µg (0.25 mg/ml) in PBS with 0.09% (W/V) sodium azide.
Applications
Dilution *
Immunohistochemistry (IHC)
1:50-1:100
Western Blot (WB)
1:100-1:500
* Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Product Specific Information
PA5-13330 targets ABAD in WB and IHC applications and shows reactivity with Human samples. The PA5-13330 immunogen is a synthetic peptide from the C-terminal region of ABAD conjugated to KLH. PA5-13330 detects ABAD which has a predicted molecular weight of approximately 27 kDa.
General Information
This gene encodes 3-hydroxyacyl-CoA dehydrogenase type II, a member of the short-chain dehydrogenase/reductase superfamily. The gene product is a mitochondrial protein that catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids. The protein has been implicated in the development of Alzheimer's disease, and mutations in the gene are the cause of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined.
Product Images
Filter :
IHC using PA5-13330
Immunohistochemistry with anti-ABAD Polyclonal Antibody (PA5-13330)